BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2301076)

  • 1. [Costs and cost analysis].
    Danneskiold-Samse B; Alban A; Pedersen KM
    Ugeskr Laeger; 1990 Jan; 152(5):298-303. PubMed ID: 2301076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of the district hospital: a case study in Malawi.
    Mills AJ; Kapalamula J; Chisimbi S
    Bull World Health Organ; 1993; 71(3-4):329-39. PubMed ID: 8324852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A review of the types of economic analyses of the health economy].
    Pedersen KM; Alban A; Danneskiold-Samsøe B
    Ugeskr Laeger; 1990 Jan; 152(3):144-8. PubMed ID: 2105550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of production factors, costs, and process efficacy in the radiology department of a local health agency in Italy.
    Mecozzi B; Pancione L; De Intinis G; Gullstrand R; Gualtieri A; Giraudo P
    Radiol Med; 2003 Mar; 105(3):215-29. PubMed ID: 12835645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tackling wastage and inefficiency in the health sector.
    Parker D; Newbrander W
    World Health Forum; 1994; 15(2):107-13; discussion 114-31. PubMed ID: 8018273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of illness: United States, 1980.
    Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
    Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gambia: cost and effectiveness of a mobile maternal health care service, West Kiang.
    Fox-Rushby JA
    World Health Stat Q; 1995; 48(1):23-7. PubMed ID: 7571706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Health services and health economics].
    Cilingiroglu N
    Nufusbil Derg; 1988; 10():45-50. PubMed ID: 12342133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calculation of workers' health care costs].
    Rydlewska-Liszkowska I
    Med Pr; 2006; 57(6):567-71. PubMed ID: 17533995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Principles of calculating net costs of health services in roentgeno-radiologic institutions].
    Belle TS; Teĭblium MM
    Vestn Rentgenol Radiol; 1993; (4):57-8. PubMed ID: 7801570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dollars and sense: a practical guide to cost analysis for hospital epidemiology and infection control.
    Chrischilles EA; Scholz DA
    Clin Perform Qual Health Care; 1999; 7(2):107-11. PubMed ID: 10747563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of hospice care.
    Robinson BE; Pham H
    Clin Geriatr Med; 1996 May; 12(2):417-28. PubMed ID: 8799358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The costs of treating HIV-infected children in Abidjan, Ivory Coast, 1996-1997].
    Giraudon I; Leroy V; Msellati P; Elenga N; Ramon R; Welffens-Ekra C; Dabis F
    Sante; 1999; 9(5):277-81. PubMed ID: 10657769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect cost in economic evaluation: the opportunity cost of unpaid inputs.
    Posnett J; Jan S
    Health Econ; 1996; 5(1):13-23. PubMed ID: 8653189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of budget impact in drug reimbursement decisions.
    Cohen JP; Stolk E; Niezen M
    J Health Polit Policy Law; 2008 Apr; 33(2):225-47. PubMed ID: 18325899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating resource use and cost of prophylactic management of neutropenia with filgrastim.
    Annemans L; Van Overbeke N; Standaert B; Van Belle S
    J Nurs Manag; 2005 May; 13(3):265-74. PubMed ID: 15819840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.